Abiopharma

🔍 Pittas Aristeidis P (Director)

Company: EUROSEAS LTD. (ESEA)

Report Date: 2026-04-14

Detailed Transactions and Holdings:

• Acquired 250 shares of Common stock at $70.2 per share (Direct)
  Date: 2026-04-14 | Code: S | equity_swap_involved: 0 | shares_owned_after: 57,800.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 250 shares of Common stock at $70.2 per share (Direct)
  Date: 2026-04-14 | Code: S | equity_swap_involved: 0 | shares_owned_after: 57,800.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: The Reporting Person owns a 25% interest and has effective control over voting and disposition of the shares owned by Family United Navigation Co. The Reporting Person disclaims beneficial ownership of the securities held by Family United Navigation Co. except to the extent of such reporting person's respective pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purpose.
• F2: The Reporting person's spouse owns 25% interest and has effective control over voting and disposition of the shares owned by Family United Navigation Co. The Reporting Person disclaims beneficial ownership of the securities held by Family United Navigation Co. except to the extent of such reporting person's respective pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purpose.